Science

NIH ends 2026 with a boost for early-career researchers, but new awards are down overall

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 08/10/2026, 16:57:24 UTC.

Briefings

The National Institutes of Health (NIH) concluded its 2026 funding cycle with a mixed outcome, utilizing its complete budget while significantly reducing the number of new grants awarded to early-career researchers. This decision resulted in a net decrease in funding opportunities for this specific demographic, despite the agency's full financial allocation.

Key points

• NIH allocated its entire 2026 budget to existing projects, leaving many applicants ineligible for new funding.
• The number of new grants awarded to early-career researchers decreased overall during the 2026 cycle.

Context

The National Institutes of Health (NIH) concluded its 2026 funding cycle with a mixed outcome, utilizing its complete budget while significantly reducing the number of new grants awarded to early-career researchers. This decision resulted in a net decrease in funding opportunities for this specific demographic.

Limitations

Evidence is limited to the headline summary provided; specific numbers, dates, or names of affected researchers are not included in the source text.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 25/10/2026, 05:03:17 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeia5x77djjlz3rix552bvzcuv6ti2twihnioezt4ltsfogl4ibna6q